互白素-1β和癌症免疫反应
Cédric Rébé1, François Ghiringhelli1
1Université Bourgogne Europe, Centre Georges-François Leclerc, Unicancer, Cancer Biology Transfer Platform, UMR INSERM 1231, TIRECs team, Equipe Labellisée LIGUE 2024, Dijon 21000, France.
Seminars in immunology
|November 2, 2025
概括
干白素-1β (IL-1β) 在癌症中起着双重作用,促进或抑制瘤的进展. 本综述分析了IL-1β对癌细胞和瘤微环境 (TME) 的影响.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 介乐金-1β (IL-1β) 是一种需要caspase-1裂变的细胞因子.
- 分泌的IL-1β与IL-1R1结合,在细胞中启动基因转录.
- 瘤相关细胞,包括免疫细胞和癌细胞,在瘤微环境 (TME) 中产生IL-1β.
研究的目的:
- 分析IL-1β对癌细胞的类效应.
- 研究IL-1β对TME内的免疫细胞的影响.
- 探索IL-1β在各种癌症类型中的上下文依赖作用.
主要方法:
- 文献综述和对IL-1β在癌症中的现有研究的分析.
- 检查IL-1β的分子作用机制.
- 跨不同癌症类型和治疗方案的比较分析.
主要成果:
- IL-1β表现出上下文依赖的功能,影响免疫反应,血管生成和癌细胞行为.
- 它对癌症进展的影响可以是前瘤或抗瘤.
- 瘤微环境和特定的癌症类型显著调节IL-1β的影响.
结论:
- 在癌症中IL-1β的双重作用需要对治疗策略的细微了解.
- 向IL-1β需要仔细考虑其在不同癌症环境中的特定影响.
- 需要进一步的研究来阐明控制IL-1β在瘤发生中的对立作用的精确机制.
更多相关视频
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Autocrine Signaling
52.0K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
52.0K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K


